May 2020 Briefing – Pathology

Here are what the editors at HealthDay consider to be the most important developments in Pathology for May 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Physician’s Briefing Weekly Coronavirus Roundup

Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of May 25 to 29, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.

Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article

Infection Risk Up in Month After CAR T-Cell Immunotherapy

FRIDAY, May 29, 2020 (HealthDay News) — For children and young adults receiving CD19 chimeric antigen receptor (CAR) T-cell infusion (CTI), infection rates increase in the first month after treatment and then decrease, according to a study published in the May issue of Open Forum Infectious Diseases.

Abstract/Full Text

Positive RT-PCR Findings Seen After COVID-19 Discharge

FRIDAY, May 29, 2020 (HealthDay News) — Some patients with COVID-19 have positive reverse transcriptase polymerase chain reaction (RT-PCR) results after discharge, according to a research letter published online May 28 in JAMA Network Open.

Abstract/Full Text

Success More Than 50 Percent for Second Child With Fertility Treatment

FRIDAY, May 29, 2020 (HealthDay News) — Women have a good chance of having a second child with the help of assisted reproductive technology (ART), according to a study published online May 8 in Human Reproduction.

Abstract/Full Text

CDC: Coronavirus Antibody Tests Still Not Accurate Enough

THURSDAY, May 28, 2020 (HealthDay News) — Coronavirus antibody test results may not be accurate enough to help guide decisions about whether to allow large groups of people to gather at work, schools, dormitories, correctional facilities, and other locations, the U.S. Centers for Disease Control and Prevention said Wednesday.

CBS News Article
More Information: CDC

Genetic Data May Up Diagnostic Efficiency for Rheumatic Disease

THURSDAY, May 28, 2020 (HealthDay News) — Converting genotype information into an interpretable probability value for five different inflammatory arthritis-causing diseases could potentially improve the diagnostic efficiency of rheumatic disease, according to a study published in the May 27 issue of Science Translational Medicine.

Abstract/Full Text (subscription or payment may be required)

9.5 Percent Uninsured in U.S. From January Through June 2019